Abstract
This report analyzes the Global Market for Nanomedicine in Millions of US$ by
the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo
Imaging, Biomaterials, and Others. Annual forecasts are provided for the
period of 2006 through 2015. The report profiles 263 companies including many
key and niche players worldwide such as Abraxis BioScience, Inc., Acusphere,
Inc., Advion Biosciences, Inc., Agilent Technologies, Inc., AMAG
Pharmaceuticals, Inc., Amgen, Inc., Arrowhead Research Corporation, Calando
Pharmaceuticals, Inc., Nanotope, Inc., Tego BioSciences Corporation, BioForce
Nanosciences, Inc., BioSante Pharmaceuticals, Inc., Crucell N.V., Elan
Corporation Plc, Elan Drug Technologies, Ensysce Biosciences, Inc., Enzon
Pharmaceuticals, Inc., eSpin Technologies, Inc., Flamel Technologies S.A.,
Johnson & Johnson, Life Technologies Corporation, Merck & Co., Inc.,
Nanobiotix, NanoCarrier Co., Ltd., Nanospectra Biosciences, Inc, Nanosphere,
Inc., Nanosys, Inc., Nektar Therapeutics, Novavax, Inc., Oxonica Plc, Par
Pharmaceutical Companies, Inc, pSivida Limited, Starpharma Holdings Limited,
Dendritic Nanotechnologies, Inc., Starpharma Pty. Ltd., and Wyeth
Pharmaceuticals, Inc. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
| 
View Cart
